Finance

Lists
544319:BOM
Senores Pharmaceuticals Ltd
₹1 258,10
-1,87%
(-23,95) 1D
15 Okt., 15:59:06 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544319...
Open
₹1 275,05
High
₹1 295,80
Low
₹1 252,00
Mkt. cap
57,98 mjd
Avg. vol.
29,95 k
Volume
16,52 k
P/E ratio
46,54
52-wk high
₹1 599,55
52-wk low
₹708,10
EPS
₹27,03
No. of employees
368
Open
₹1 275,05
High
₹1 295,80
Low
₹1 252,00
Mkt. cap
57,98 mjd
Avg. vol.
29,95 k
Volume
16,52 k
P/E ratio
46,54
52-wk high
₹1 599,55
52-wk low
₹708,10
EPS
₹27,03
No. of employees
368
News stories
From web sources and news partners
About Senores Pharmaceuticals Ltd
CEO-
Employees368
Founded2017
Headquarters-
SectorPharmaceutical industry
Websitesenorespharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,53 mjd
1,65 mjd
1,93 mjd
1,80 mjd
Cost of goods sold
570,80 m
670,20 m
748,40 m
657,20 m
Cost of revenue
570,80 m
670,20 m
748,40 m
657,20 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
296,30 m
306,60 m
365,40 m
299,10 m
Operating expense
548,70 m
517,00 m
971,90 m
706,70 m
Total operating expenses
1,12 mjd
1,19 mjd
1,72 mjd
1,36 mjd
Operating income
414,10 m
461,40 m
213,50 m
438,20 m
Other non operating income
54,10 m
37,90 m
-126,20 m
28,10 m
EBT including unusual items
406,30 m
446,00 m
474,10 m
394,60 m
EBT excluding unusual items
406,30 m
446,00 m
467,10 m
394,60 m
Income tax expense
105,10 m
110,20 m
107,30 m
90,10 m
Effective tax rate
25,87%
24,71%
22,63%
22,83%
Other operating expenses
171,50 m
131,80 m
513,50 m
308,20 m
Net income
323,80 m
316,60 m
316,20 m
307,20 m
Net profit margin
21,11%
19,20%
16,35%
17,05%
Earnings per share
6,54
7,29
7,96
6,60
Interest and investment income
-
-
140,00 m
-
Interest expense
-61,90 m
-53,30 m
-72,80 m
-71,70 m
Net interest expenses
-61,90 m
-53,30 m
67,20 m
-71,70 m
Depreciation and amortization charges
80,90 m
78,60 m
93,00 m
99,40 m
EBITDA
484,55 m
499,80 m
277,00 m
516,32 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme